Malin Corp. provides an update in respect of its investment in Viamet Pharmaceuticals and Mycovia Pharmaceuticals; expects to write-off investment (€6.90, 0.00)
EU' CHMP adopted a positive opinion, recommending the granting of a marketing authorisation for Gedeon Richter's medicinal product Inijaq (12930.00Ft, +150.00)
Gedeon Richter initiated neutral at Oddo (12580.00Ft, 0.00)
Transcript Intelligence: Gedeon Richter Q2 Earnings Guidance
Transcript Intelligence: Gedeon Richter Q2 Earnings Themes
Transcript Intelligence: Gedeon Richter Q2 Earnings Q&A
Gedeon Richter downgraded to hold from buy at HSBC (12630.00Ft, 0.00)
Transcript Intelligence: Gedeon Richter Q1 Earnings Guidance
Transcript Intelligence: Gedeon Richter Q1 Earnings Themes
Transcript Intelligence: Gedeon Richter Q1 Earnings Q&A
Powered by FactSet Research Systems Inc.